Skip to main content
. 2021 Sep 22;41(9):BSR20211494. doi: 10.1042/BSR20211494

Table 2. The interaction between upstream regulators and miR-375.

Tumor type Upstream regulator Number tumor samples Compared with normal tissues Reference
Bladder cancer circKIF4A 50 Up [129]
OS CircFAT1 12 Up [53]
OS Circ 0060428 Four cells Up [56]
ESCC circLPAR3 50 Up [116]
GC lncRNA MLK7-AS1 5 Up [130]
GC lncRNA TINCR 56 Up [131]
GC hsa_circ_0008035 30 Up [132]
HCC CircZFR 40 Up [133]
SCLC Circ_0086720 52 Up [49]
HCC Hsa_circ_101280 21 Up [134]
CRC Circ-PRKDC 30 Up [135]
Cervical cancer circEPSTI1 Two cells Up [136]
OS lncRNA TUSC7 30 Up [68]
CRC lncRNA-SNHG17 45 Up [70]
Neuroblastoma lncRNA XIST 36 Up [137]
HCC LncRNA CCAT1 Two cells Up [138]
Gliomas lncRNA RP11‐626G11.3 42 Up [139]
PTC LINC02471 50 Up [88]
liver cancer lncRNA MALAT1 20 Up [140]
Glioma lncRNA KCNQ1OT1 43 Up [141]
Glioma lncRNA LUCAT1 38 Up [142]
LAC lncRNA ROR1-AS1 50 Up [89]
OSCC LncRNA SNHG17 40 Up [125]